Drug Trial Radar · NCT04962867
NCCH2006/MK010 Trial (FORTUNE Trial)
Last checked: Nov 19, 2026Latest source record: Oct 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
75
Planned (sponsor's estimate)
Start
Jun 15, 2021
Primary completion
Mar 31, 2028
Study completion Mar 31, 2028
Sponsor
- Lead sponsor
- National Cancer Center, JapanGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- Collaborators
- Eisai Co., Ltd.
- First posted
- Jul 15, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a single-arm, open-label, multicenter, investigator-initiated Phase 2 trial to evaluate the efficacy and safety of E7090 in patients with advanced or recurrent solid tumors harboring FGFR genetic alterations (including fusion, mutation, amplification).
Conditions
- Advanced or Recurrent Solid Tumors
- FGFR Gene Alterations
Interventions
E7090Drug
140 mg of E7090 is orally administered once daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective response rate (ORR)Time frame: Baseline up to 3.5 years
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Tohoku University Hospital
Aoba-ku, Sendai, Miyagi, Japan · Recruiting
Kyushu University Hospital
Higashi-Ku, Fukuoka, Japan · Recruiting
Hokkaido University Hospital
Kita-Ku, Sapporo, Hokkaido, Japan · Recruiting
Okayama University Hospital
Okayama, Japan · Recruiting
Kyoto University Hospital
Sakyo-ku, Kyoto, Japan · Recruiting
National Cancer Center Hospital
Chuo-ku, Tokyo, Japan, Japan · Recruiting
Kanagawa Cancer Center
Yokohama, Kanagawa, Japan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.